On Air Now

Listen

Listen Live Now » 98.5 FM Battle Creek, Michigan

Weather

Current Conditions(Battle Creek,MI 49017)

More Weather »
49° Feels Like: 44°
Wind: NNW 12 mph Past 24 hrs - Precip: 0”
Current Radar for Zip

Tonight

Showers Late 44°

Tomorrow

AM Rain 60°

Sat Night

Mostly Clear 39°

Alerts

GSK says melanoma combination meets main goal

LONDON (Reuters) - GlaxoSmithKline said on Friday the first of its phase three studies into the combination of Tafinlar and Mekinist to treat melanoma, the deadliest form of skin cancer, had met its main goal.

The results, along with further data expected from the study, will increase the body of evidence on the safety and efficiacy of the combination, the British company said.

The combined use of Tafinlar, also known as dabrafenib, and Mekinist, or trametinib, was given the green light from the Food and Drug Administration (FDA) in the U.S. earlier this month.

(Reporting by Kate Holton, Editing by Paul Sandle)

Comments